Metabolic crosstalk between host and pathogen: Sensing, adapting and competing

Nature Reviews Microbiology

Volumn 14, Issue 4, 2016, Pages 221-234

  Olive, Andrew J ^a   Sassetti, Christopher M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; BACTERIAL PROTEIN; VIRULENCE FACTOR;

ADAPTATION; CHEMICAL COMPOSITION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNE RESPONSE; MICROBIAL METABOLISM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIBRIO CHOLERAE; BACTERIUM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; RISK FACTOR;

BACTERIA; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; RISK FACTORS; VIRULENCE FACTORS;

EID: 84961052338     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.12     Document Type: Review

References (141)

1. Rohmer L, Hocquet D, & Miller S. I. Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol. 19, 341-348 (2011).
2. Vance R. E, Isberg R. R, & Portnoy D. A. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe. 6, 10-21 (2009).
3. Xayarath B, & Freitag N. E. Optimizing the balance between host and environmental survival skills: lessons learned from Listeria monocytogenes. Future Microbiol. 7, 839-852 (2012).
4. Vakulskas C. A, Potts A. H, Babitzke P, Ahmer B. M, & Romeo T. Regulation of bacterial virulence by Csr (Rsm) systems. Microbiol. Mol. Biol. Rev. 79, 193-224 (2015).
5. Heroven A. K, & Dersch P. Coregulation of host-Adapted metabolism and virulence by pathogenic yersiniae. Front. Cell. Infect. Microbiol. 4, 146 (2014).
6. Ferrando M. L, et al. Carbohydrate availability regulates virulence gene expression in Streptococcus suis. PLoS ONE 9, e89334 (2014).
7. Pacheco A. R, et al. Fucose sensing regulates bacterial intestinal colonization. Nature. 492, 113-117 (2012).
8. Houot L, Chang S, Absalon C, & Watnick P. I. Vibrio cholerae phosphoenolpyruvate phosphotransferase system control of carbohydrate transport, biofilm formation, and colonization of the germfree mouse intestine. Infect. Immun. 78, 1482-1494 (2010).
9. Prouty A. M, Brodsky I. E, Falkow S, & Gunn J. S. Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella Typhimurium. Microbiology. 150, 775-783 (2004).
10. Yang M, et al. Bile salt-induced intermolecular disulfide bond formation activates Vibrio cholerae virulence. Proc. Natl Acad. Sci. USA. 110, 2348-2353 (2013).
11. Olive A. J, et al. Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle. Infect. Immun. 75, 2626-2629 (2007).
12. Sun Y, Wilkinson B. J, Standiford T. J, Akinbi H. T, & O?Riordan M. X. Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes. J. Bacteriol. 194, 5274-5284 (2012).
13. Lobel L, Sigal N, Borovok I, Ruppin E, & Herskovits A. A. Integrative genomic analysis identifies isoleucine and CodY as regulators of Listeria monocytogenes virulence. PLoS Genet. 8, e1002887 (2012).
14. Lobel L, et al. The metabolic regulator CodY links Listeria monocytogenes metabolism to virulence by directly activating the virulence regulatory gene prfA. Mol. Microbiol. 95, 624-644 (2015).
15. Baruch M, et al. An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell. 156, 97-108 (2014).
16. Baruch M, et al. Induction of endoplasmic reticulum stress and unfolded protein response constitutes a pathogenic strategy of group A Streptococcus. Front. Cell. Infect. Microbiol. 4, 105 (2014).
17. Cywes Bentley C, Hakansson A, Christianson J, & Wessels M. R. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling. Cell. Microbiol. 7, 945-955 (2005).
18. Barbosa-Tessmann I. P, et al. Activation of the unfolded protein response pathway induces human asparagine synthetase gene expression. J. Biol. Chem. 274, 31139-31144 (1999).
19. Gjymishka A, Su N, & Kilberg M. S. Transcriptional induction of the human asparagine synthetase gene during the unfolded protein response does not require the ATF6 and IRE1/XBP1 arms of the pathway. Biochem. J. 417, 695-703 (2009).
20. Rittershaus E. S, Baek S. H, & Sassetti C. M. The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe. 13, 643-651 (2013).
21. Steinhaus E. A, & Birkeland J. M. Studies on the life and death of bacteria: I. The senescent phase in aging cultures and the probable mechanisms involved. J. Bacteriol. 38, 249-261 (1939).
22. Betts J. C, Lukey P. T, Robb L. C, McAdam R. A, & Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717-731 (2002).
23. Wayne L. G. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am. Rev. Respir. Dis. 114, 807-811 (1976).
24. Jones S. E, & Lennon J. T. Dormancy contributes to the maintenance of microbial diversity. Proc. Natl Acad. Sci. USA. 107, 5881-5886 (2010).
25. Lillebaek T, et al. Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J. Infect. Dis. 188, 1032-1039 (2003).
26. Manina G, & McKinney J. D. A single-cell perspective on non-growing but metabolically active (NGMA) bacteria. Curr. Top. Microbiol. Immunol. 374, 135-161 (2013).
27. Gengenbacher M, Rao S. P, Pethe K, & Dick T. Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology. 156, 81-87 (2010).
28. Rao S. P, Alonso S, Rand L, Dick T, & Pethe K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA. 105, 11945-11950 (2008).
29. Voskuil M. I, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198, 705-713 (2003).
30. Daniel J, et al. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186, 5017-5030 (2004).
31. Sakharkar K. R, Dhar P. K, & Chow V. T. Genome reduction in prokaryotic obligatory intracellular parasites of humans: a comparative analysis. Int. J. Syst. Evol. Microbiol. 54, 1937-1941 (2004).
32. Clarke I. N. Evolution of Chlamydia trachomatis. Ann. NY Acad. Sci. 1230, E11-E18 (2011).
33. Pfefferkorn E. R. Interferon-? blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. Sci. USA. 81, 908-912 (1984).
34. Yoshida R. Imanishi J, Oku T, Kishida T, & Hayaishi O. Induction of pulmonary indoleamine 2, 3 dioxygenase by interferon. Proc. Natl Acad. Sci. USA. 78, 129-132 (1981).
35. MacKenzie C. R, Heseler K, Muller A, & Daubener W. Role of indoleamine 2, 3 dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr. Drug Metab. 8, 237-244 (2007).
36. Stephens R. S, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science. 282, 754-759 (1998).
37. Fehlner-Gardiner C, et al. Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J. Biol. Chem. 277, 26893-26903 (2002).
38. Thomas S. M, et al. IFN-?-mediated antimicrobial response. Indoleamine 2, 3 dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J. Immunol. 150, 5529-5534 (1993).
39. Wood H, et al. Regulation of tryptophan synthase gene expression in Chlamydia trachomatis. Mol. Microbiol. 49, 1347-1359 (2003).
40. Beatty W. L, Belanger T. A, Desai A. A, Morrison R. P, & Byrne G. I. Tryptophan depletion as a mechanism of ?-interferon-mediated chlamydial persistence. Infect. Immun. 62, 3705-3711 (1994).
41. Belland R. J, et al. Transcriptome analysis of chlamydial growth during IFN-?-mediated persistence and reactivation. Proc. Natl Acad. Sci. USA. 100, 15971-15976 (2003).
42. Baek S. H, Li A. H, & Sassetti C. M. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 9, e1001065 (2011).
43. Park H. D, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48, 833-843 (2003).
44. Coers J, et al. Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infections. PLoS Pathog. 7, e1001346 (2011).
45. Nelson D. E, et al. Chlamydial IFN-? immune evasion is linked to host infection tropism. Proc. Natl Acad. Sci. USA. 102, 10658-10663 (2005).
46. Zhang Y. J, et al. Tryptophan biosynthesis protects mycobacteria from CD4 T cell-mediated killing. Cell. 155, 1296-1308 (2013).
47. Pearce E. L, & Pearce E. J. Metabolic pathways in immune cell activation and quiescence. Immunity. 38, 633-643 (2013).
48. Appelberg R. Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 79, 1117-1128 (2006).
49. Xu S, et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol. 153, 2568-2578 (1994).
50. Smith A. C, et al. A network of Rab GTPases controls phagosome maturation and is modulated by Salmonella enterica serovar Typhimurium. J. Cell Biol 176 263-268 (2007).
51. Beatty W. L, et al. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. 1, 235-247 (2000).
52. Clemens D. L, & Horwitz M. A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 184, 1349-1355 (1996).
53. Fratti R. A, Vergne I, Chua J, Skidmore J, & Deretic V. Regulators of membrane trafficking and Mycobacterium tuberculosis phagosome maturation block. Electrophoresis. 21, 3378-3385 (2000).
54. Tan S, & Russell D. G. Trans-species communication in the Mycobacterium tuberculosis-infected macrophage. Immunol. Rev. 264, 233-248 (2015).
55. Pandey A. K, & Sassetti C. M. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl Acad. Sci. USA. 105, 4376-4380 (2008).
56. Griffin J. E, et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7, e1002251 (2011).
57. Rothchild A. C, Jayaraman P, Nunes-Alves C, & Behar S. M. iNKT cell production of GM CSF controls Mycobacterium tuberculosis. PLoS Pathog. 10, e1003805 (2014).
58. Eisele N. A, et al. Salmonella require the fatty acid regulator PPARd for the establishment of a metabolic environment essential for long-Term persistence. Cell Host Microbe. 14, 171-182 (2013).
59. Xavier M. N, et al. PPAR?-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. Cell Host Microbe. 14, 159-170 (2013).
60. Deutscher J. The mechanisms of carbon catabolite repression in bacteria. Curr. Opin. Microbiol. 11, 87-93 (2008).
61. Silo-Suh L, Suh S. J, Phibbs P. V, & Ohman D. E. Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose 6 phosphate dehydrogenase. J. Bacteriol. 187, 7561-7568 (2005).
62. de Carvalho L. P, et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co catabolism of carbon substrates. Chem. Biol. 17, 1122-1131 (2010).
63. Marrero J, Trujillo C, Rhee K. Y, & Ehrt S. Glucose phosphorylation is required for Mycobacterium tuberculosis persistence in mice. PLoS Pathog. 9, e1003116 (2013).
64. Beckman J. S, Beckman T. W, Chen J, Marshall P. A, & Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA. 87, 1620-1624 (1990).
65. Clementi E, Brown G. C, Feelisch M, & Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl Acad. Sci. USA. 95, 7631-7636 (1998).
66. Lamichhane G. Mycobacterium tuberculosis response to stress from reactive oxygen and nitrogen species. Front. Microbiol. 2, 176 (2011).
67. Richardson A. R, Dunman P. M, & Fang F. C. The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol. Microbiol. 61, 927-939 (2006).
68. Richardson A. R, Libby S. J, & Fang F. C. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319 1672-1676 (2008).
69. Vitko N. P, Spahich N. A, & Richardson A. R. Glycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus. mBio 6, e00045 15 (2015).
70. Michelucci A, et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl Acad. Sci. USA. 110, 7820-7825 (2013).
71. Eoh H, & Rhee K. Y. Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids. Proc. Natl Acad. Sci. USA. 111, 4976-4981 (2014).
72. Dunn M. F, Ramirez-Trujillo J. A, & Hernandez-Lucas I. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology. 155, 3166-3175 (2009).
73. Eckburg P. B, et al. Diversity of the human intestinal microbial flora. Science. 308, 1635-1638 (2005).
74. Frank D. N, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA. 104, 13780-13785 (2007).
75. Vujkovic-Cvijin I, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl Med. 5, 193ra91 (2013).
76. Winter S. E, & Baumler A. J. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes. 5, 71-73 (2014).
77. Winter S. E, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 339, 708-711 (2013).
78. Lopez C. A, et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. mBio 3, e00143 12 (2012).
79. Winter S. E, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 467, 426-429 (2010).
80. Hensel M, Hinsley A. P, Nikolaus T, Sawers G, & Berks B. C. The genetic basis of tetrathionate respiration in Salmonella Typhimurium. Mol. Microbiol. 32, 275-287 (1999).
81. Ali M. M, et al. Fructose-Asparagine is a primary nutrient during growth of Salmonella in the inflamed intestine. PLoS Pathog. 10, e1004209 (2014).
82. Morris R. L, & Schmidt T. M. Shallow breathing: bacterial life at low O2. Nat. Rev. Microbiol. 11, 205-212 (2013).
83. Thomson N. R, et al. The complete genome sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica strain 8081. PLoS Genet. 2, e206 (2006).
84. Orme I. M, & Basaraba R. J. The formation of the granuloma in tuberculosis infection. Semin. Immunol. 26, 601-609 (2014).
85. Peng K, & Monack D. M. Indoleamine 2, 3 dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs. Infect. Immun. 78, 2723-2733 (2010).
86. Chu P, Rodriguez A. R, Arulanandam B. P, & Klose K. E. Tryptophan prototrophy contributes to Francisella tularensis evasion of ?-interferon-mediated host defense. Infect. Immun. 79, 2356-2361 (2011).
87. Gouzy A, et al. Mycobacterium tuberculosis exploits asparagine to assimilate nitrogen and resist acid stress during infection. PLoS Pathog. 10, e1003928 (2014).
88. Powell J. D, & Delgoffe G. M. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity. 33, 301-311 (2010).
89. Avramis V. I, & Tiwari P. N. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int. J. Nanomed. 1, 241-254 (2006).
90. van der Velden A. W, Velasquez M, & Starnbach M. N. Salmonella rapidly kill dendritic cells via a caspase 1 dependent mechanism. J. Immunol. 171, 6742-6749 (2003).
91. Srinivasan A, Nanton M, Griffin A, & McSorley S. J. Culling of activated CD4 T cells during typhoid is driven by Salmonella virulence genes. J. Immunol. 182, 7838-7845 (2009).
92. Kullas A. L, et al. l asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence. Cell Host Microbe 12 791-798 (2012).
93. Gouzy A, et al. Mycobacterium tuberculosis nitrogen assimilation and host colonization require aspartate. Nat. Chem. Biol. 9, 674-676 (2013).
94. Gesbert G, et al. Asparagine assimilation is critical for intracellular replication and dissemination of Francisella. Cell. Microbiol. 16, 434-449 (2014).
95. Burrack K. S, & Morrison T. E. The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front. Immunol. 5, 428 (2014).
96. Abu-Lubad M, Meyer T. F, & Al Zeer M. A. Chlamydia trachomatis inhibits inducible NO synthase in human mesenchymal stem cells by stimulating polyamine synthesis. J. Immunol. 193, 2941-2951 (2014).
97. Diep B. A, et al. Complete genome sequence of USA300, an epidemic clone of community-Acquired methicillin-resistant Staphylococcus aureus. Lancet. 367, 731-739 (2006).
98. Diep B. A, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 197, 1523-1530 (2008).
99. Joshi G. S, Spontak J. S, Klapper D. G, & Richardson A. R. Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol. Microbiol. 82, 9-20 (2011).
100. Thurlow L. R, et al. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe. 13, 100-107 (2013).
101. Attia A. S, et al. Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe. 11, 664-673 (2012).
102. Medzhitov R, Preston-Hurlburt P, & Janeway C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388, 394-397 (1997).
103. Lightfield K. L, et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-Terminal domain of flagellin. Nat. Immunol. 9, 1171-1178 (2008).
104. Hornung V, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase 1 activating inflammasome with ASC. Nature. 458, 514-518 (2009).
105. Fernandes-Alnemri T, Yu J. W, Datta P, Wu J, & Alnemri E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 458, 509-513 (2009).
106. Sander L. E, et al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature. 474, 385-389 (2011).
107. Gaudet R. G, et al. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science. 348, 1251-1255 (2015).
108. Watson R. O, Manzanillo P. S, & Cox J. S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell. 150, 803-815 (2012).
109. Kofoed E. M, & Vance R. E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature. 477, 592-595 (2011).
110. Woodward J. J, Iavarone A. T, & Portnoy D. A. c di AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328 1703-1705 (2010).
111. Gallo P. M, et al. Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity. 42, 1171-1184 (2015).
112. Jain V, Kumar M, & Chatterji D. ppGpp: stringent response and survival. J. Microbiol. 44, 1-10 (2006).
113. Karaolis D. K, et al. c di GMP (3' 5' cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Antimicrob. Agents Chemother. 49, 1029-1038 (2005).
114. Whiteley A. T, Pollock A. J, & Portnoy D. A. The PAMP c di AMP is essential for Listeria growth in macrophages and rich but not minimal media due to a toxic increase in (p)ppGpp. Cell Host Microbe. 17, 788-798 (2015).
115. Corrigan R. M, Abbott J. C, Burhenne H, Kaever V, & Grundling A. c di AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog 7 e1002217 (2011).
116. Burdette D. L, et al. STING is a direct innate immune sensor of cyclic di GMP. Nature. 478, 515-518 (2011).
117. Yang J, et al. Deletion of the cyclic di AMP phosphodiesterase gene (cnpB) in Mycobacterium tuberculosis leads to reduced virulence in a mouse model of infection. Mol. Microbiol. 93, 65-79 (2014).
118. Dey B, et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nat. Med. 21, 401-406 (2015).
119. Martinon F, Burns K, & Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell. 10, 417-426 (2002).
120. Broz P, et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745-1755 (2010).
121. Wynosky-Dolfi M. A, et al. Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J. Exp. Med. 211, 653-668 (2014).
122. Tannahill G. M, et al. Succinate is an inflammatory signal that induces IL 1β through HIF 1α. Nature. 496, 238-242 (2013).
123. Eoh H, & Rhee K. Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA. 110, 6554-6559 (2013).
124. Franchini M. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am. J. Hematol. 81, 202-209 (2006).
125. Allen K. J, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358, 221-230 (2008).
126. Barber M. F, & Elde N. C. Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science. 346, 1362-1366 (2014).
127. Barton J. C, & Acton R. T. Hemochromatosis and Vibrio vulnificus wound infections. J. Clin. Gastroenterol. 43, 890-893 (2009).
128. Sinkovics J. G, Cormia F, & Plager C. Hemochromatosis and Listeria infection. Arch. Intern. Med. 140, 284 (1980).
129. Oellerich M. F, et al. Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect. Immun. 75, 3802-3811 (2007).
130. Olynyk J. K, et al. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341, 718-724 (1999).
131. Fisher-Hoch S. P, Mathews C. E, & McCormick J. B. Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases. Trop. Med. Int. Health. 18, 1510-1519 (2013).
132. Saravu K, et al. Melioidosis in southern India: epidemiological and clinical profile. Southeast Asian J. Trop. Med. Publ. Health. 41, 401-409 (2010).
133. Kumari P, & Meena L. S. Factors affecting susceptibility to Mycobacterium tuberculosis: a close view of immunological defence mechanism. Appl. Biochem. Biotechnol. 174, 2663-2673 (2014).
134. Martinez N, & Kornfeld H. Diabetes and immunity to tuberculosis. Eur. J. Immunol. 44, 617-626 (2014).
135. Zoka A, et al. Altered immune regulation in type 1 diabetes. Clin. Dev. Immunol. 2013, 254874 (2013).
136. Betteridge D. J. Lipid control in patients with diabetes mellitus. Nat. Rev. Cardiol. 8, 278-290 (2011).
137. Singhal A, et al. Metformin as adjunct antituberculosis therapy. Sci. Transl Med. 6, 263ra159 (2014).
138. Getahun H, Matteelli A, Chaisson R. E, & Raviglione M. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 372, 2127-2135 (2015).
139. Schiebler M, et al. Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion. EMBO Mol. Med. 7, 127-139 (2015).
140. Lobato L. S, et al. Statins increase rifampin mycobactericidal effect. Antimicrob. Agents Chemother. 58, 5766-5774 (2014).
141. Mahajan S, et al. Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPAR? and TR4 for survival. J. Immunol. 188, 5593-5603 (2012).